The Liver in Children With Metabolic Syndrome

Ebe D'Adamo, Valeria Castorani, Valerio Nobili

Research output: Contribution to journalReview article

Abstract

Non-alcoholic fatty liver disease (NAFLD) is recognized as an emerging health risk in obese children and adolescents. NAFLD represents a wide spectrum of liver conditions, ranging from asymptomatic steatosis to steatohepatitis. The growing prevalence of fatty liver disease in children is associated with an increased risk of metabolic and cardiovascular complications. NAFLD is considered the hepatic manifestation of Metabolic Syndrome (MetS) and several lines of evidence have reported that children with NAFLD present one or more features of MetS. The pathogenetic mechanisms explaining the interrelationships between fatty liver disease and MetS are not clearly understood. Altough central obesity and insulin resistance seem to represent the core of the pathophysiology in both diseases, genetic susceptibility and enviromental triggers are emerging as crucial components promoting the development of NAFLD and MetS in children. In the present review we have identified and summarizied studies discussing current pathogenetic data of the association between NAFLD and MetS in children.

Original languageEnglish
Pages (from-to)514
JournalFrontiers in Endocrinology
Volume10
DOIs
Publication statusPublished - 2019

Fingerprint

Liver
Fatty Liver
Liver Diseases
Asymptomatic Diseases
Abdominal Obesity
Disease Susceptibility
Genetic Predisposition to Disease
Insulin Resistance
Non-alcoholic Fatty Liver Disease
Health

Cite this

The Liver in Children With Metabolic Syndrome. / D'Adamo, Ebe; Castorani, Valeria; Nobili, Valerio.

In: Frontiers in Endocrinology, Vol. 10, 2019, p. 514.

Research output: Contribution to journalReview article

D'Adamo, Ebe ; Castorani, Valeria ; Nobili, Valerio. / The Liver in Children With Metabolic Syndrome. In: Frontiers in Endocrinology. 2019 ; Vol. 10. pp. 514.
@article{4a551b3ae4e94fd3a700531baebd06fb,
title = "The Liver in Children With Metabolic Syndrome",
abstract = "Non-alcoholic fatty liver disease (NAFLD) is recognized as an emerging health risk in obese children and adolescents. NAFLD represents a wide spectrum of liver conditions, ranging from asymptomatic steatosis to steatohepatitis. The growing prevalence of fatty liver disease in children is associated with an increased risk of metabolic and cardiovascular complications. NAFLD is considered the hepatic manifestation of Metabolic Syndrome (MetS) and several lines of evidence have reported that children with NAFLD present one or more features of MetS. The pathogenetic mechanisms explaining the interrelationships between fatty liver disease and MetS are not clearly understood. Altough central obesity and insulin resistance seem to represent the core of the pathophysiology in both diseases, genetic susceptibility and enviromental triggers are emerging as crucial components promoting the development of NAFLD and MetS in children. In the present review we have identified and summarizied studies discussing current pathogenetic data of the association between NAFLD and MetS in children.",
author = "Ebe D'Adamo and Valeria Castorani and Valerio Nobili",
year = "2019",
doi = "10.3389/fendo.2019.00514",
language = "English",
volume = "10",
pages = "514",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - The Liver in Children With Metabolic Syndrome

AU - D'Adamo, Ebe

AU - Castorani, Valeria

AU - Nobili, Valerio

PY - 2019

Y1 - 2019

N2 - Non-alcoholic fatty liver disease (NAFLD) is recognized as an emerging health risk in obese children and adolescents. NAFLD represents a wide spectrum of liver conditions, ranging from asymptomatic steatosis to steatohepatitis. The growing prevalence of fatty liver disease in children is associated with an increased risk of metabolic and cardiovascular complications. NAFLD is considered the hepatic manifestation of Metabolic Syndrome (MetS) and several lines of evidence have reported that children with NAFLD present one or more features of MetS. The pathogenetic mechanisms explaining the interrelationships between fatty liver disease and MetS are not clearly understood. Altough central obesity and insulin resistance seem to represent the core of the pathophysiology in both diseases, genetic susceptibility and enviromental triggers are emerging as crucial components promoting the development of NAFLD and MetS in children. In the present review we have identified and summarizied studies discussing current pathogenetic data of the association between NAFLD and MetS in children.

AB - Non-alcoholic fatty liver disease (NAFLD) is recognized as an emerging health risk in obese children and adolescents. NAFLD represents a wide spectrum of liver conditions, ranging from asymptomatic steatosis to steatohepatitis. The growing prevalence of fatty liver disease in children is associated with an increased risk of metabolic and cardiovascular complications. NAFLD is considered the hepatic manifestation of Metabolic Syndrome (MetS) and several lines of evidence have reported that children with NAFLD present one or more features of MetS. The pathogenetic mechanisms explaining the interrelationships between fatty liver disease and MetS are not clearly understood. Altough central obesity and insulin resistance seem to represent the core of the pathophysiology in both diseases, genetic susceptibility and enviromental triggers are emerging as crucial components promoting the development of NAFLD and MetS in children. In the present review we have identified and summarizied studies discussing current pathogenetic data of the association between NAFLD and MetS in children.

U2 - 10.3389/fendo.2019.00514

DO - 10.3389/fendo.2019.00514

M3 - Review article

C2 - 31428049

VL - 10

SP - 514

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

ER -